CellPlan is a revolutionary stem cell insurance product launched by WideCells Group in Manchester, UK. WideCells Group aims to provide people with access to affordable stem cell treatments. In this interview, CEO Joao Andrade describes how the company will facilitate the therapeutic use of umbilical cord blood stem cells by providing worldwide access to stem cell specialists and hospitals.
In this article: